Apilan, Faustino .

HRN: 27-60-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2025
CLOXACILLIN 500MG (CAP)
08/16/2025
08/29/2025
PO
500mg
Q6hours
Abscess
Checking Initial Appropriateness 

 Indication:  Empirical De-escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines